Eris to acquire 2 Biocon Bio units for ₹366 crore
Mint Mumbai|November 09, 2023
Nephrology, dermatology units have 20 brands with ₹90 cr FY23 revenue
Ranjani Raghavan
Eris to acquire 2 Biocon Bio units for ₹366 crore

Eris Lifesciences Ltd. said it has signed a definitive agreement to purchase the nephrology and dermatology segments of Biocon Biologics Ltd.'s branded formulations business in India for 366 crore. 

The acquired units, encompassing more than 20 major brands, reported a turnover of 90 crore in fiscal year 2023, with a current revenue run-rate of 100 crore.

The deal, which includes the transfer of working capital, will see over 120 personnel, including senior leaders and field staff, transition to Eris Lifesciences. The transaction is likely to achieve financial closure by the end of 2023.

هذه القصة مأخوذة من طبعة November 09, 2023 من Mint Mumbai.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

هذه القصة مأخوذة من طبعة November 09, 2023 من Mint Mumbai.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

المزيد من القصص من MINT MUMBAI مشاهدة الكل
Reduction of energy costs in the telecom sector
Mint Mumbai

Reduction of energy costs in the telecom sector

With telecom infrastructure companies looking for newer ways to cut back on energy costs, battery restoration technology provides telecom infrastructure firms with a viable, economical and green solution for uninterrupted power supply

time-read
5 mins  |
November 15, 2024
Skip cheese and sip wine in Switzerland
Mint Mumbai

Skip cheese and sip wine in Switzerland

Beyond chocolates and cheese, there's another Swiss gem to discover — vineyards that have been passed down through the generations

time-read
4 mins  |
November 15, 2024
Mint Mumbai

Bankers aren't always frank about bank regulation

The 'world's banker' Jamie Dimon, CEO of JPMorgan Chase, speaks his mind even if it means taking swipes at US regulators.

time-read
4 mins  |
November 15, 2024
Baku: A climate breakthrough looks depressingly bleak today
Mint Mumbai

Baku: A climate breakthrough looks depressingly bleak today

The success of fossil fuel-favouring politics threatens the planet

time-read
3 mins  |
November 15, 2024
Global solidarity levies can play a vital role in our climate efforts
Mint Mumbai

Global solidarity levies can play a vital role in our climate efforts

Solidarity taxes could support redistributive measures and optimize how we collectively tackle a great challenge of our times

time-read
3 mins  |
November 15, 2024
Speak for the Earth: It's the least we should do
Mint Mumbai

Speak for the Earth: It's the least we should do

This year's Booker prize winner turns our gaze to the planet from orbit and reminds us of the climate disaster that looms. Can odes sung to Earth move the world to act in its defence?

time-read
3 mins  |
November 15, 2024
Mint Mumbai

Aim for an efficient carbon market right from the start

India's economy is projected to grow dramatically over the next few decades. In nominal terms, it may double in size by 2030. This is exciting, but it comes with a significant risk.

time-read
3 mins  |
November 15, 2024
Mint Mumbai

Why health insurers refuse to cover certain treatments

While 12 modern treatments are covered, many advanced procedures are yet to be included

time-read
3 mins  |
November 15, 2024
Mint Mumbai

Address economic distress with structural reforms and not doles

Cash transfers may offer short-term relief but raising worker incomes is the only lasting solution

time-read
3 mins  |
November 15, 2024
Mint Mumbai

FUNDING FOREIGN EDUCATION: SHOULD YOU SAVE OR BORROW?

Education financing needs vary, but early planning is key to building your desired corpus

time-read
2 mins  |
November 15, 2024